|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Department of Pediatrics, University of Pittsburgh School of Medicine
2 From the Department of Wilford Hall Medical Center, Lackland AFR, and the Department of Anesthesiology and Critical Care Medicine, Pediatrics, Center for Clinical Pharmacology, University of Pittsburgh School of Medicine
3 From the Department of Hematology, University of Pittsburgh School of Medicine
4 From the Department of Family Medicine and Clinical Epidemiology, University of Pittsburgh School of Medicine
Study objectives: To determine the circulating anti-inflammatory cytokine interleukin 10 (IL-10) response during the development of sepsis-induced multiple organ failure in children.
Design: Prospective study.
Setting: University pediatric ICU.
Patients: Fifty-three consecutive children with sepsis and 15 critically ill children without sepsis.
Interventions: Plasma IL-10, interleukin 6 (IL-6), and nitrite+nitrate (stable end products of nitric oxide) levels and an organ failure index (OFI indicating the number of failing organ systems) were determined in 53 children on days 1 to 3 of sepsis and in control children on day 1. The effect of exogenous human IL-10 or neutralizing IL-10 antibody on supernatant IL-6 levels in ex vivo whole blood culture from 17 children on day 1 of sepsis.
Measurements and results: Children with three or more organ failures had higher plasma IL-10 levels than children with less than 3 organ failures (days 1 and 3; p<0.05). Children who developed sequential pulmonary/hepatic/renal failure had higher IL-10 levels (days 1 to 3; p<0.05). Nonsurvivors had higher IL-10 levels (day 3; p<0.05). IL-10 levels correlated with IL-6 levels (days 1 and 2) and nitrite+nitrate levels (days 1 and 3; p<0.05). Whole blood samples incubated ex vivo with exogenous recombinant human IL-10 had decreased supernatant IL-6 levels (p<0.05) and neutralizing IL-10 antibody showed no significant effect.
Conclusion: A persistent compensatory anti-inflammatory cytokine response characterizes sepsis-induced multiple organ failure. Administration of exogenous IL-10 may inhibit the early proinflammatory response; however, identification of individual immune responsiveness and possibility of persistent infection could be important to rational use in the later stages of pediatric sepsis.
Key Words: children compensatory anti-inflammatory response syndrome interleukin 6 interleukin 10 multiple organ failure nitric oxide sepsis
Submitted on June 17, 1997
Accepted on October 23, 1997
This article has been cited by other articles:
![]() |
P. C. Ng, K. Li, T. F. Leung, R. P.O. Wong, G. Li, K. M. Chui, E. Wong, F. W.T. Cheng, and T. F. Fok Early Prediction of Sepsis-Induced Disseminated Intravascular Coagulation with Interleukin-10, Interleukin-6, and RANTES in Preterm Infants Clin. Chem., June 1, 2006; 52(6): 1181 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsuda, H. Takahashi, M. Kobayashi, T. Hanafusa, D. N. Herndon, and F. Suzuki CCL2, a product of mice early after systemic inflammatory response syndrome (SIRS), induces alternatively activated macrophages capable of impairing antibacterial resistance of SIRS mice J. Leukoc. Biol., August 1, 2004; 76(2): 368 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Q. Latifi, M. A. O'Riordan, and A. D. Levine Interleukin-10 Controls the Onset of Irreversible Septic Shock Infect. Immun., August 1, 2002; 70(8): 4441 - 4446. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Alcaraz, L. Sancho, L. Manzano, F. Esquivel, A. Carrillo, A. Prieto, E. D. Bernstein, and M. Alvarez-Mon Newborn patients exhibit an unusual pattern of interleukin 10 and interferon {gamma} serum levels in response to cardiac surgery J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 451 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Adams and B. L. Tepperman Colonic production and expression of IL-4, IL-6, and IL-10 in neonatal suckling rats after LPS challenge Am J Physiol Gastrointest Liver Physiol, April 1, 2001; 280(4): G755 - G762. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |